ShareValue scores for BP8.AU: Valuation 54, Quality 25, Growth 43, Health 55.

BP8.AU
ASX

BPH Global Ltd

A$0.00(0.00%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 17%
Valuation
54
Fair Value
Price vs Value
Quality
25
Weak
Business Strength
Growth
43
Moderate
Revenue & Earnings
Health
55
Moderate
Financial Stability
Momentum
42
Neutral
Price Trend

Company Details

About

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. BPH Global Ltd was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. The company was incorporated in 1984 and is headquartered in Melbourne, Australia.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026